ANE Regional Activities

>> Regional Overview >> ANE Regional Activities Overview

ACTIVITY DATA SHEET PROGRAM: Asia and the Near East Regional TITLE AND NUMBER: Asia & the Near East Regional HIV/AIDS and Infectious Disease Program, 498-029 STATUS: Continuing PLANNED FY 2001 OBLIGATION AND FUNDING SOURCE: None. PROPOSED FY 2002 OBLIGATION AND FUNDING SOURCE: None. INITIAL OBLIGATION: FY 2000    ESTIMATED COMPLETION DATE: FY 2002 Summary: The Asia and Near East Regional HIV/AIDS and Infectious Disease program (498-029), started in June 2000, incorporated elements of the ANE Regional HIV/AIDS program (498-008) that was notified in the FY 2001 Budget Justification. The new activity was developed to provide a more integrated response to HIV/AIDS and infectious disease (ID) health issues, which often are related. The only obligation under this objective was in FY 2000. Funds under this activity will be expended by FY 2001, and the objective will be terminated. This objective is being replaced by a new integrated strategic objective, "Stabilize Population Growth and Protect Human Health" (498-022). Key Results: The activity increased the number interventions to prevent, treat, or control IDs in mobile populations; expanded the number of countries with national ID prevalence and behavioral surveillance systems; and increased the number of implementing partners adopting best practices or new ID services. Performance and Prospects: HIV/AIDS activities include the following: (1) HIV and STI surveillance in border areas in the Mekong region; (2) a seafarers intervention project targeting ports in Indonesia and Thailand; (3) regional training to expand the capacity of community organizations to provide and support for people living with AIDS; (4) cross-border HIV prevention programs in Nepal, India, and Thailand; (5) regional training for HIV program managers; (6) HIV/AIDS prevention activities in four provinces in Vietnam; (7) condom social marketing in Laos and Vietnam; and (8) an assessment of training needs for HIV voluntary counseling and testing programs in Vietnam, India, and Nepal. Infectious disease activities include the following: (1) training on surveillance of drug-resistant malaria and related drug-use practices and drug quality in South and Southeast Asia; (2) developing and testing interventions, including new treatment regimens, to slow emergence and spread of drug-resistant malaria and improve the use of antimalarial drugs in Southeast Asia; and (3) standardizing surveillance and training methodologies for monitoring vector-borne diseases such as malaria in South Asia. Possible Adjustments to Plans: Starting in FY 2001, funds will be obligated and activities will be reported under the regional objective "Stabilize Population Growth and Protect Human Health" (498-022). Other Donors: Key donors include the United Nations Joint Program on HIV/AIDS; the United Kingdom; the European Union; the United Nations Development Program; Japan; Australia; the Ford Foundation; Germany; the World Health Organization; and the World Bank. Principal Contractors, Grantees, or Agencies: Contractors and grantees include Family Health International/IMPACT; PSI/AIDSMARK; the International HIV/AIDS Alliance; the Population Council/HORIZONS; and TVT Associates/SYNERGY. Infectious disease partners include: Abt Associates; Asian Collaborative Training Network for Malaria; Camp Dresser and McKee International; the Centers for Disease Control and Prevention; the Centre for Development and Population Activities; International Union Against TB and Lung Disease; the Johns Hopkins University; Kenan Institute of Asia, Thailand; Management Sciences for Health; TB Coalition for Technical Assistance; the U.S. Pharmacopeia Convention, Inc.; and the World Health Organization. Selected Performance Indicators:   Baseline (2000) Target (2002) Number of interventions targeting mobile populations Implemented 4 5 Number of socially marketed condoms sold in non-presence countries (millions) 50 55 Innovative models developed and disseminated for: prevention, treatment, care, and support of persons affected by HIV or ID 5 6 U.S. Financing (In thousands of dollars)   Obligations   Expenditures   Unliquidated   Through September 30, 1999    0 DA 0 DA 0 DA 0 CSD 0 CSD 0 CSD 0 ESF 0 ESF 0 ESF 0 SEED 0 SEED 0 SEED 0 FSA 0 FSA 0 FSA 0 DFA 0 DFA 0 DFA Fiscal Year 2000 0 DA 0 DA   5,000 CSD 0 CSD 0 ESF 0 ESF 0 SEED 0 SEED 0 FSA 0 FSA 0 DFA 0 DFA Through September 30, 2000 0 DA 0 DA 0 DA 5,000 CSD 0 CSD 5,000 CSD 0 ESF 0 ESF 0 ESF 0 SEED 0 SEED 0 SEED 0 FSA 0 FSA 0 FSA 0 DFA 0 DFA 0 DFA Prior Year Unobligated Funds 0 DA   0 CSD 0 ESF 0 SEED 0 FSA 0 DFA Planned Fiscal Year 2001 NOA 0 DA   0 CSD 0 ESF 0 SEED 0 FSA 0 DFA Total Planned Fiscal Year 2001 0 DA   0 CSD 0 ESF 0 SEED 0 FSA 0 DFA       Future Obligations   Est. Total Cost   Proposed Fiscal Year 2002 NOA 0 DA 0 DA 0 DA 0 CSD 0 CSD 5,000 CSD 0 ESF 0 ESF 0 ESF 0 SEED 0 SEED 0 SEED 0 FSA 0 FSA 0 FSA 0 DFA 0 DFA 0 DFA The FY 2001 and future activities and funding related to this SO have been moved to SO 498-022.

:  :  :  :  :  :  :  :  :  :  What's New : FOIA Requests : Privacy Policy : Email This Page : Plug-ins : FAQs : Help Desk : Contact Us : Site Map Last Updated on: May 29, 2002